A major impediment to improving brain tumor outcomes is poor clinical trial accrual. In fact, only 20 percent of neuro-oncology patients enroll in clinical trials. Surveys of brain tumor patients
Preliminary Results of ABTA Metastatic Brain Tumor Initiative Patient and Caregiver Survey Presented at the American Society Clinical Oncology Annual Meeting The American Brain Tumor Association presented preliminary survey
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest oncology meetings attracting more than 33,000 researchers and medical professionals from around the world. In addition
With its Metastatic Brain Tumor Initiative, the American Brain Tumor Association (ABTA) is taking the lead to ensure patients diagnosed with brain metastases are represented in clinical trials and have
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
